On June 7th, Zai Ding Pharmaceutical (ZLAB) fell by 2.04% during trading hours, closing at $18.7 per share as of 02:29, with a total trading volume of $5,801,300.
Financial data as of March 31, 2024, shows that Zai Ding Pharmaceutical had a total revenue of $87.149 million, an increase of 38.78% year-over-year. However, the net profit attributable to shareholders was -$53.471 million, a decrease of 8.8% year-over-year.
